International Edition
Latest News
Health

NHS Confirms Double Vaccine for Adults Aged 65-80

NHS Launches Combined RSV and Flu Vaccination Program for Older Adults The NHS is providing a combined vaccination approach for adults aged 65 and older to protect against both respiratory syncytial virus (RSV) and seasonal influenza. According to…

NHS Confirms Double Vaccine for Adults Aged 65-80

NHS Launches Combined RSV and Flu Vaccination Program for Older Adults

The NHS is providing a combined vaccination approach for adults aged 65 and older to protect against both respiratory syncytial virus (RSV) and seasonal influenza. According to UK government health guidelines, this strategy aims to reduce winter hospital admissions by targeting two of the most common causes of severe respiratory illness in the elderly.

RSV Vaccination Eligibility and Access

The NHS has introduced the RSV vaccine specifically for older adults because the virus can cause severe pneumonia and exacerbate chronic heart or lung conditions. While flu vaccines are an annual requirement, the RSV vaccine is being rolled out to specific age cohorts based on clinical risk. According to the UK Health Security Agency (UKHSA), the priority is to shield those most likely to suffer complications, starting with the oldest age groups and those in residential care.

How the Combined Vaccination Schedule Works

Patients do not receive a single “combo shot” in one syringe; rather, the NHS coordinates the administration of both the flu vaccine and the RSV vaccine during the same autumn appointment window. This “double vaccine” approach increases uptake by reducing the number of clinic visits required. According to NHS guidance, these vaccines can be administered simultaneously in different arms without reducing the efficacy of either dose.

Comparing RSV and Influenza Risks in Seniors

While both viruses attack the respiratory system, they differ in their impact and prevention methods. The following table outlines the distinctions based on UKHSA and NHS data:

Feature Influenza (Flu) RSV
Frequency Annual booster required Initial rollout for high-risk elderly
Primary Risk Systemic fever, pneumonia Severe lower respiratory tract infection
Target Age 65+ and clinically vulnerable 65-80+ (phased rollout)

Reducing Winter Pressure on Healthcare

The decision to prioritize these vaccinations stems from data showing a spike in “co-infections,” where a patient contracts both viruses simultaneously. According to reports from the Department of Health and Social Care, co-infections significantly increase the likelihood of ICU admission and prolonged hospital stays. By providing both protections, the NHS intends to lower the burden on A&E departments during the peak winter months.

Frequently Asked Questions

Can I get the RSV and flu vaccine at the same time?

Yes. The NHS confirms that it’s safe to receive both vaccinations during the same appointment, typically administered in different arms.

Who is eligible for the RSV vaccine?

Eligibility is currently focused on adults aged 65 and over, with priority given to those in the 75-80+ range and individuals with underlying health conditions, according to UKHSA protocols.

Are there side effects to getting both vaccines?

Common side effects reported by the NHS include soreness at the injection site, mild fatigue, or a low-grade fever. These are standard immune responses and typically resolve within 48 hours.

Vaccine Recommendations for Older Adults
About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”